Strategic advice from experts you trust

Weekly Gist

Welcome to the Weekly Gist, where we distill the latest healthcare news, trends and our conversations with industry leaders into actionable guidance for CEOs and senior executives.
For more insights like these, subscribe to the Weekly Gist and receive an executive-level analysis of the week’s news delivered your inbox every Friday.

Search for Keywords

Filter by Category

Filter by Date

The Weekly Gist: The Tapas Box Blues Edition

The FDA approves a major new Alzheimer's drug, despite concerns over its efficacy and enormous price tag. Meanwhile, a major health insurer delays a controversial new payment policy.
Read More

The Weekly Gist: The Bugs Gone Wild Edition

President Biden's massive $6B budget for the next fiscal year lacks any specific details on two key healthcare campaign promises. Meanwhile, an AI-driven telemedicine company makes a big play for physicians in California.
Read More

The Weekly Gist: The Unmasked! Edition

Federal public health authorities suddenly reversed course on masking, leaving states and businesses scrambling to reorient. Meanwhile, Missouri backtracks on its Medicaid expansion plans.
Read More

The Weekly Gist: The Rosebud or Marmalade Edition

President Biden proposes major new healthcare spending under his $4T recovery plan, but excludes drug cost reform and Medicare expansion. Meanwhile, CMS proposes favorable 2022 payments for hospitals.
Read More

The Weekly Gist: The Upside Only Soccer Edition

The US is nearing a new, more difficult phase of the COVID vaccine rollout, with daily vaccination rates down 11 percent this week. Meanwhile, the Biden administration's showdown with Texas over Medicaid expansion intensified.
Read More